Community Academic Profiles–

Joachim Hallmayer

Back to Profile

Publication Details

  • A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder.

    Paterson R, Douglas C, Hallmayer J, Hagan M, Krupenia Z. Aust N Z J Psychiatry. 1999; 33 (4): 494-502

    The aim of this paper is to determine the efficacy of dexamphetamine in adult attention deficit hyperactivity disorder (ADHD) in a naturalistic setting.

    PubMedID: 10483843

Stanford Medicine Resources:

Footer Links: